Advertisement

Topics

Biotest Austria GmbH Company Profile

00:59 EST 25th November 2017 | BioPortfolio

Die nachfolgenden Geschäftsbedingungen gelten für alle unsere Lieferungen und Leistungen, sofern sie nicht durch eine ausdrückliche schriftliche Vereinbarung mit uns abgeändert oder ausgeschlossen werden. Bedingungen des Käufers wird ausdrücklich widersprochen.Unsere Angebote und Verkaufsunterlagen (z.B. Preislisten) sind freibleibend und unverbindlich, soweit nicht das Gegenteil ausdrücklich festgestellt wird. Die Übersendung von Katalogen, Prospekten oder Preislisten verpflichtet uns nicht zur Lieferung. Aufträge gelten erst als angenommen, wenn sie von uns geliefert oder schriftlich bestätigt werden.
Unsere Lieferungen und Leistungen im Fernabsatz (Webshop) bieten wir nur Kunden mit Sitz bzw. Wohnsitz in Österreich an. Die Abgabe unserer Arzneispezialitäten unterliegt dem Arzneimittelgesetz.

Location

Einsiedlergasse 58
Wien
1053
Austria

Contact

Phone: 01 / 545 15 61 - 0
Fax: 01 / 545 15 61
Email: info@biotest.at


News Articles [238 Associated News Articles listed on BioPortfolio]

Biotest, Curetis Agree to Use Unyvero IAI Test for Pentaglobiin Trial

Curetis will use its recently approved Unyvero intra-abdominal infection (IAI) cartridge diagnostic to test patients enrolled in the Biotest’s PEPPER Pentaglobin® Peritonitis Trial for IAIs and...

Biotest, Curetis Agree to Use Unyvero IAI Test for Pentaglobin Trial

Curetis will use its recently approved Unyvero intra-abdominal infection (IAI) cartridge diagnostic to test patients enrolled in the Biotest’s PEPPER Pentaglobin ® Peritonitis Trial for IAIs an...

Guten Morgen mit Biotest, CropEnergies, Gerresheimer ...

BIO3Biotest AG: Biotest stärkt Position im wichtigen Hämophilie-Markt Deutschland durch neuen Patientenservice CE2CropEnergies erhöht in H1 weiter Umsatz und Ergebnis - Ethanolproduktion steigt um ...

Cheplapharm gets rights to sell Orexigen's Mysimba in Germany, France, and Austria

Orexigen Therapeutics Inc. granted Cheplapharm Arzneimittel GMBH rights to commercialize and distribute the obesity drug Mysimba (naltrexone HCl/bupropion HCl prolonged release) in Germany, France, an...

US Denies Approval for Creat's $1.5 Billion Acquisition of Germany's Biotest

Creat Group of China has withdrawn its current $1.5 billion offer to acquire Biotest, a German blood plasma products corporation, because US regulators refused to approve the deal. According to Bloomb...

Biotest relocates Florida plasma center, ups workforce

Biotest Pharmaceuticals Corporation has relocated its Plasma Center in Pembroke Pines, Florida, US.

Biotech Report: Evotec und Biotest tiefrot

shareribs.com - Biotech-Aktien zeigten sich im deutschen Handel heute überwiegend leichter. Deutlich unter Druck lagen Biotest und Evotec. An der Wall Street zeigt sich ebenfalls ein durchwachsenes.....

China's Creat suffers setback in Biotest deal on U.S. scrutiny

FRANKFURT (Reuters) - Chinese investor Creat Group Corp has withdrawn its application for U.S. approval of a planned 1.3-billion-euro ($1.51-billion) takeover of Biotest , the German blood plasma prod...

PubMed Articles [63 Associated PubMed Articles listed on BioPortfolio]

Clinical presentation and management of stable coronary artery disease in Austria.

Cardiovascular disease is the main cause of death in Austria. However, no systematic information exists regarding characteristics and treatments of contemporary patients with stable coronary artery di...

Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.

By using pediatric diabetes quality registries in Austria, Germany, and Sweden treatment of type 1 diabetes and the outcome of care during the vulnerable adolescence period were compared.

Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.

We analysed all female breast cancer (BC) cases in Tyrol/Austria regarding the shift in cancer characteristics, especially the shift in advanced BC, for the group exposed to screening as compared to t...

Quality Indicators of Primary Health Care Facilities in Austria.

Background The strengthening of primary health care is one major goal of the current national health reform in Austria. In this context, a new interdisciplinary concept was developed in 2014 that defi...

Configuration of multiple human stressors and their impacts on fish assemblages in Alpine river basins of Austria.

This work addresses multiple human stressors and their impacts on fish assemblages of the Drava and Mura rivers in southern Austria. The impacts of single and multiple human stressors on riverine fish...

Clinical Trials [90 Associated Clinical Trials listed on BioPortfolio]

Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT)

The purpose of the "Supporting Carers of Children and Adolescents with Eating Disorders in Austria" (SUCCEAT) - study is to compare Workshop, Internet-based and Conventional Parental Suppo...

MyoRing Implantation With Corneal Collagen Crosslinking for Keratoconus

A complete intrastromal ring, MyoRing (Dioptex, GmbH, Linz, Austria), suggested by Albert Daxer in 2007, is a relatively new technique that has been demonstrated to treat keratoconus safel...

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

The study seeks to provide evidence of the effectiveness and obtain patient reported outcome (PRO) and work productivity data of the interferon-free ABBVIE REGIMEN +/- Ribavirin (RBV) in c...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [593 Associated Companies listed on BioPortfolio]

Biotest Diagnostics Corporation

Biotest Diagnostics Corporation is the U.S. subsidiary of Biotest AG with headquarters in Frankfurt am Main, Germany. Biotest is involved in the development, production and marketing of pharmaceutica...

CROMA Pharma, GmbH

CROMA Pharma, GmbH, is a private global specialty pharmaceutical and surgical company dedicated to improving people’s health through the development and commercialization of ...

Biotest Seralc

Biotest AG is vandaag één van de meest innovatieve organisaties op de markt van de klinische diagnostiek. Wij produceren en verkopen producten voor klinische laboratoria in 4 gebieden: bloedtransfus...

Biotest

We have been successfully operating in North America for over 20 years, and have built a reputation for quality products and exceptional customer service.Based in Denville, New Jersey, we are a wholly...

Biotest Austria GmbH

Die nachfolgenden Geschäftsbedingungen gelten für alle unsere Lieferungen und Leistungen, sofern sie nicht durch eine ausdrückliche schriftliche Vereinbarung mit uns abgeändert oder ausgeschlossen...

More Information about "Biotest Austria GmbH" on BioPortfolio

We have published hundreds of Biotest Austria GmbH news stories on BioPortfolio along with dozens of Biotest Austria GmbH Clinical Trials and PubMed Articles about Biotest Austria GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotest Austria GmbH Companies in our database. You can also find out about relevant Biotest Austria GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record